Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: Application to antipsychotic drugs
Jf. Liegeois et al., Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: Application to antipsychotic drugs, ARCH BIOCH, 370(1), 1999, pp. 126-137
Some antipsychotic agents have been found to produce agranulocytosis and ap
lastic anemia. The oxidation phenomena and/or the formation of free radical
s has been suggested to be causally related to various hematological disord
ers, e.g., agranulocytosis, Using five experimental conditions, we tested t
he oxidative potential of compounds with and without a history of hematolog
ical side effects, e.g., agranulocytosis and aplastic anemia. A statistical
analysis was undertaken for each experimental condition and a multivariate
analysis combining all results was performed. Two peroxidase-induced free
radical models did not successfully discriminate between drugs with and wit
hout a history of causing hematologic problems (<70%). The lipid peroxidati
on system provided even less satisfactory discrimination, with only 56.25%
correct classification. However, an 87.5% correct classification was obtain
ed when using the oxidation potentials of these drugs determined at pH 4.7
and at pH 7.4, A multivariate analysis taking into account the five variabl
es provided 87.5% success in classification, The two clusters were better d
iscriminated in terms of a "distance coefficient." In a second analysis, th
e putative antipsychotic pyridobenzodiazepine analogues (JL5, JL8, JL18, an
d JL25) were classified in the cluster of toxic compounds, while the oxa- a
nd thiazepine analogues (JL2, JL3, and JL13) were classified as nontoxic co
mpounds, On the other hand, a few metabolites of clozapine and fluperlapine
were classified in the toxic compound group. The procedure described herei
n is, to our knowledge, the first which classifies molecules of different s
tructures as well. as different pharmacological profiles according to their
hematotoxic potential. Such a procedure could be used to predict drug-indu
ced hematological side effects. (C) 1999 Academic Press.